Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
about
Fibrates for primary prevention of cardiovascular disease eventsDiabetes DyslipidemiaClustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapyFibrates for primary prevention of cardiovascular disease events.New frontiers in the treatment of diabetic dyslipidemiaA genome-wide study of lipid response to fenofibrate in Caucasians: a combined analysis of the GOLDN and ACCORD studies.Peroxisome proliferator-activated receptors and atherosclerosis.Targeting the ABCB4 gene to control cholesterol homeostasis.New lipid-lowering drugs: an update.Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemia.The need for combination drug therapies in patients with complex dyslipidemia.Fibrates and niacin: is there a place for them in clinical practice?Role of PPARα and Its Agonist in Renal Diseases.Niacin: the only vitamin that reduces cardiovascular events.All at sea: new lipid-lowering drug trials continue to disappoint.Doubling up: maximising statin therapy as opposed to adding other drugs for cardiovascular disease prevention.Effective kinetics of schisandrin B on serum/hepatic triglyceride and total cholesterol levels in mice with and without the influence of fenofibrate.
P2860
Q24203618-74C11055-E510-4703-8171-0B0A642CFD5EQ26750905-C73B96FA-9BAA-45D4-9E38-9C7F2D165858Q28728567-CED69957-A6D2-40A9-B797-8A46519429A5Q30241199-484F9BBF-E9FE-4C95-93F0-568E4E65F82EQ33776236-B298BC1A-7481-4B0C-9DAA-2B239536F5F3Q37179792-1CAE5D87-E021-40F2-BFD1-C7DF7150FB29Q37861955-BE225B7A-75CD-47BE-A222-E0484E84CA1CQ37908143-3A06B042-41B1-4BA0-BC97-77943E514A47Q37984782-C2792AC1-7FB9-4BF2-974C-B16BE1D923C0Q38001736-5A23C3F3-E71B-4954-8061-10F547261D5FQ38118163-290EC904-987E-4D2F-8A80-34900D52CC58Q38260501-6825DD3B-8014-4778-B884-0163279D39F2Q39817316-1B4B3287-3521-4ECB-B2DF-1A8FE116F27EQ44004071-D140520E-9614-46BF-A34D-D64FD7C48CB9Q45420980-48028B8B-9E6A-4589-B4A7-C0006AEB8BCDQ46380487-4A8C2DC8-4CFB-4B64-A1DB-7979DDE07E39Q46464754-F0CB721F-2C53-4F14-8BED-0DCDF8D3D2F4
P2860
Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
@en
Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
@nl
type
label
Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
@en
Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
@nl
prefLabel
Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
@en
Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
@nl
P1476
Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
@en
P304
P356
10.1097/MOL.0B013E32833C1E74
P577
2010-08-01T00:00:00Z